Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04370093
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-09-01T00:04:58.406538+00:00
Published At
2026-08-31T00:00:00+00:00
Record Updated At
2026-08-31
Results Posted At
2026-08-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Nephrolithiasis, Uric Acid"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-08-31"
protocolSection.identificationModule.nctId
"NCT04370093"
protocolSection.identificationModule.officialTitle
"Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-08-31"

Study condition terms

  • Nephrolithiasis, Uric Acid (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.